ADMA Biologics ADMA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 17.15 | 101.94 | 20.51 | 0.46 | 38,323 | 112 |
| 2024Q3 | 19.99 | 98.48 | 68.39 | 0.14 | 39,638 | 36 |
| 2024Q2 | 11.18 | 98.91 | 0.13 | 39,201 | 32 | |
| 2024Q1 | 6.60 | 98.43 | 0.08 | 21,821 | 18 | |
| 2023Q4 | 4.52 | -124.52 | -0.08 | 14,233 | -18 | |
| 2023Q3 | 3.58 | 96.90 | 0.01 | 8,685 | 3 | |
| 2023Q2 | 3.69 | 666.20 | -0.03 | -473 | -6 | |
| 2023Q1 | 3.31 | 120.80 | -0.03 | -813 | -7 | |
| 2022Q4 | 3.88 | 93.29 | -0.06 | -6,059 | -12 | |
| 2022Q3 | 2.43 | 99.98 | -0.07 | -9,317 | -15 | |
| 2022Q2 | 1.98 | 99.82 | -0.07 | -9,175 | -14 | |
| 2022Q1 | 1.83 | 68.53 | -0.13 | -14,815 | -25 | |
| 2021Q4 | 1.41 | 98.93 | -0.07 | -13,191 | -17 | |
| 2021Q3 | 1.13 | 100.16 | -0.13 | -14,437 | -18 | |
| 2021Q2 | 1.60 | 99.51 | -0.15 | -15,581 | -19 | |
| 2021Q1 | 1.76 | 99.87 | -0.16 | -15,164 | -18 | |
| 2020Q4 | 1.95 | 105.66 | -0.20 | -17,220 | -19 | |
| 2020Q3 | 2.39 | 99.82 | -0.19 | -13,801 | -17 | |
| 2020Q2 | 2.93 | 100.08 | -0.23 | -17,124 | -20 | |
| 2020Q1 | 2.88 | 101.46 | -0.26 | -16,770 | -19 |